title: PARP inhibitors for chemoprevention--reply.
authors.affiliation: Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire.
authors.forename: Ciric
authors.initials: C
authors.lastname: To
authors.affiliation: Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire.
authors.forename: Michael B
authors.initials: MB
authors.lastname: Sporn
authors.affiliation: Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire. Karen.T.Liby@dartmouth.edu.
authors.forename: Karen T
authors.initials: KT
authors.lastname: Liby
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019313:BRCA1 Protein / Q000502:physiology*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015674:Mammary Neoplasms, Animal / Q000517:prevention & control*; D010793:Phthalazines / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors
chemical_list: D000970:Antineoplastic Agents; D019313:BRCA1 Protein; D001562:Benzimidazoles; D010793:Phthalazines; D010879:Piperazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors